Purchase Order HHSN272201401099P

Award Date 9/11/14
Potential Completion Date 9/30/14
Potential Value $6.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Petaluma, CA, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for the delivery of primer probes. The contract is a Blanket Purchase Agreement (BPA) call valued at $626,838.00, with an ultimate completion date of July 30, 2022. Biosearch Technologies, through its LGC Biosearch Technologies division, is a privately held company that specializes in the design, development, and manufacture of oligonucleotide-based tools. This...
This is a firm fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc., a privately held company specializing in oligonucleotide-based tools. The contract, valued at $87,500.00, is for the provision of laboratory equipment. Biosearch Technologies has a history of providing laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support the CDC, Department of Defense, and National...
This federal contract award to Biosearch Technologies, Inc. LGC Biosearch Technologies Division, a privately held manufacturer of oligonucleotide-based tools, is for the provision of primers and probes. The $127,000.00 firm fixed price purchase order was issued by the Centers for Disease Control and Prevention (CDC) to support disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens such as influenza, COVID-19, Ebola, and Brucella....
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price delivery order contract to Biosearch Technologies, Inc. LGC Biosearch Technologies Division. The $787,500.00 contract, which has no set-aside designation, is for the provision of oligonucleotide-based laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides. These products support the CDC's disease surveillance, diagnostic testing, public health research,...
This $62,965.40 firm fixed price purchase order was awarded by the Bureau of Medicine and Surgery, a defense agency, to Biosearch Technologies, Inc.'s LGC Biosearch Technologies division. The contract is for the delivery of DLO-FB1-2 dual-labeled probe, with a completion date of July 31, 2025. Biosearch Technologies is a privately held company that specializes in the design, development, and manufacture of oligonucleotide-based tools. The company has a history of providing laboratory supplies,...
This is a federal contract award to Biosearch Technologies, Inc. LGC Biosearch Technologies Division, a privately-held company that specializes in the design, development, and manufacture of oligonucleotide-based tools. The contract, awarded by the Centers for Disease Control and Prevention (CDC) under the Department of Health and Human Services, is an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a potential value of $145,400.00. It is a firm fixed price contract with no...
This is a $236,603.20 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC), which is part of the Department of Health and Human Services, to Biosearch Technologies, Inc. The award is for the provision of RUO (Research Use Only) oligonucleotides. Biosearch Technologies is a manufacturer of oligonucleotide-based tools, including fluorophores and dark quenchers, and has previously provided laboratory supplies such as primer probes, assay kits, PCR kits,...
The Centers for Disease Control and Prevention (CDC) awarded a $1,343,205.50 firm fixed-price contract to Biosearch Technologies, Inc. LGC Biosearch Technologies Division to provide primer probes. This award was not set aside for any specific business type. Biosearch Technologies has a history of providing laboratory supplies like assay kits, PCR kits, and oligonucleotides to support disease surveillance, diagnostic testing, public health research, and emergency response efforts for federal...
This is a firm fixed price delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for $98,400.00. The contract, which has no set-aside designation, is for the provision of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support disease surveillance, diagnostic testing, public health research, and emergency response efforts related to pathogens like influenza, COVID-19, Ebola, and Brucella....
This is a firm fixed price Blanket Purchase Agreement (BPA) call order awarded by the Centers for Disease Control and Prevention (CDC) to Biosearch Technologies, Inc. for $164,625.00. The contract is for the delivery of laboratory kits, with no set-aside designation. Biosearch Technologies, through its LGC Biosearch Technologies division, has provided a variety of laboratory supplies such as primer probes, assay kits, PCR kits, and oligonucleotides to support the CDC's public health research and...

This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Biosearch Technologies, Inc. LGC Biosearch Technologies Division. The contract, worth $6,489.45, is for the delivery of primers and oligonucleotides to support NIAID's research and diagnostic efforts. The contract has a total small business set-aside designation. Biosearch Technologies, a private company specializing in oligonucleotide-based tools, has previously held federal contracts with agencies like the CDC, Department of Defense, and NIH to provide laboratory supplies for disease surveillance, diagnostic testing, and emergency response. The company also holds a $19 million Blanket Purchase Agreement with the CDC to facilitate procurement of reagents and kits for the Laboratory Response Network, which supports public health laboratories nationwide.

Generated 11/24/24, 9:29 AM